Philips reports Q2 adjusted EPS EUR 0.36 vs. EUR 0.30 last year

Reports Q2 revenue EUR 4.34B vs. EUR 4.46B last year. Reports Q2 comparable sales up 1%. Reports Q2 adjusted EBITDA EUR 747M vs. EUR 733M last year. Roy Jakobs, CEO of Royal Philips (PHG): “We are focused on driving profitable growth and delivering better care for more people. We built order intake growth momentum, supported by our recently launched AI-powered innovations. Our multi-year agreement with the Indonesian Ministry of Health reinforces the impact for patients of our industry-leading innovations as we provide nationwide coverage for image-guided therapy, expanding access to cardiac, stroke and cancer care for millions. Sales improved, including accelerated Personal Health sales growth, and we delivered margin expansion through innovation and productivity. We are strengthening our fundamentals through the hard work of our employees around the world. Our focus on innovation and strong execution is driving impact as we continue to put patient safety and quality as our number one priority. We did what we said we would do in the first half of the year and remain on track. We increase our full year outlook for margin and free cash flow, including currently announced tariff levels, and we reiterate our comparable sales growth outlook as we continue to build order and sales momentum.”